Within-host rhinovirus evolution in upper and lower respiratory tract highlights capsid variability and mutation-independent compartmentalization

Background Human rhinovirus (HRV) infections can progress from the upper (URT) to lower (LRT) respiratory tract in immunocompromised individuals, causing high rates of fatal pneumonia. Little is known about how HRV evolves within hosts during infection. Methods We sequenced HRV complete genomes from 12 hematopoietic cell transplant patients with prolonged infection for up to 190 days from both URT (nasal wash, NW) and LRT (bronchoalveolar lavage, BAL) specimens. Metagenomic (mNGS) and amplicon-based NGS were used to study the emergence and evolution of intra-host single nucleotide variants (iSNVs). Results Identical HRV intra-host populations in matched NW and BAL specimens indicated no genetic adaptation is required for HRV to progress from URT to LRT. Microbial composition between matched NW and BAL confirmed no cross-contamination during sampling procedure. Coding iSNVs were 2.3-fold more prevalent in capsid over non-structural genes, adjusted for length. iSNVs modeled onto HRV capsid structures were significantly more likely to be found in surface residues, but were not preferentially located in known HRV neutralizing antibody epitopes. Newly emergent, serotype-matched iSNV haplotypes from immunocompromised individuals from 2008-2010 could be detected in Seattle-area community HRV sequences from 2020-2021. Conclusion HRV infections in immunocompromised hosts can progress from URT to LRT with no specific evolutionary requirement. Capsid proteins carry the highest variability and emergent mutations can be detected in other, including future, HRV sequences.

[1]  Changchong Li,et al.  A multicenter study on molecular epidemiology of rhinovirus isolated from children with community acquired pneumonia in China during 2017-2019. , 2022, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[2]  F. Giardina,et al.  Molecular Epidemiology of Rhinovirus/Enterovirus and Their Role on Cause Severe and Prolonged Infection in Hospitalized Patients , 2022, Microorganisms.

[3]  Wei Wang,et al.  Molecular epidemiology and clinical characterization of human rhinoviruses circulating in Shanghai, 2012-2020 , 2022, Archives of Virology.

[4]  U. Liebert,et al.  Human Rhinoviruses in Adult Patients in a Tertiary Care Hospital in Germany: Molecular Epidemiology and Clinical Significance , 2021, Viruses.

[5]  L. Delang,et al.  Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus species , 2020, bioRxiv.

[6]  Olga Chernomor,et al.  IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era , 2019, bioRxiv.

[7]  Jennifer Lu,et al.  Improved metagenomic analysis with Kraken 2 , 2019, Genome Biology.

[8]  M. Sorror,et al.  Human Rhinovirus Infections in Hematopoietic Cell Transplant Recipients: Risk Score for Progression to Lower Respiratory Tract Infection , 2018, Biology of Blood and Marrow Transplantation.

[9]  W. Leisenring,et al.  Initial High Viral Load Is Associated with Prolonged Shedding of Human Rhinovirus in Allogeneic Hematopoietic Cell Transplant Recipients , 2018, Biology of Blood and Marrow Transplantation.

[10]  A. des Georges,et al.  Viral Entry Properties Required for Fitness in Humans Are Lost through Rapid Genomic Change during Viral Isolation , 2018, mBio.

[11]  Andrew N. Hashikawa,et al.  Heterotypic Infection and Spread of Rhinovirus A, B, and C among Childcare Attendees , 2018, The Journal of infectious diseases.

[12]  J. Bloom,et al.  Parallel evolution of influenza across multiple spatiotemporal scales , 2017, eLife.

[13]  A. von Haeseler,et al.  UFBoot2: Improving the Ultrafast Bootstrap Approximation , 2017, bioRxiv.

[14]  W. Leisenring,et al.  Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality , 2017, Haematologica.

[15]  J. Englund,et al.  Rule-Out Outbreak: 24-Hour Metagenomic Next-Generation Sequencing for Characterizing Respiratory Virus Source for Infection Prevention , 2017, Journal of the Pediatric Infectious Diseases Society.

[16]  A. Lauring,et al.  Measurements of Intrahost Viral Diversity Are Extremely Sensitive to Systematic Errors in Variant Calling , 2016, Journal of Virology.

[17]  P. Danaher,et al.  Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults , 2015, Journal of Clinical Virology.

[18]  H. Goossens,et al.  Prolonged shedding of rhinovirus and re-infection in adults with respiratory tract illness , 2014, European Respiratory Journal.

[19]  C. Fraser,et al.  Genome Sequences of Rhinovirus A Isolates from Wisconsin Pediatric Respiratory Studies , 2014, Genome Announcements.

[20]  J. Wedzicha,et al.  Human rhinovirus infection during naturally occurring COPD exacerbations , 2014, European Respiratory Journal.

[21]  P. Simmonds,et al.  Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types , 2013, The Journal of general virology.

[22]  T. Walsh,et al.  Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients , 2013, Transplant infectious disease : an official journal of the Transplantation Society.

[23]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[24]  Heng Li Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[25]  K. St. George,et al.  Human Rhinoviruses , 2013, Clinical Microbiology Reviews.

[26]  L. Farinelli,et al.  Rhinovirus Genome Variation during Chronic Upper and Lower Respiratory Tract Infections , 2011, PloS one.

[27]  M. Lee,et al.  Bacteremia caused by Brevundimonas species at a tertiary care hospital in Taiwan, 2000–2010 , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[28]  L. Farinelli,et al.  Rhinovirus Genome Evolution during Experimental Human Infection , 2010, PloS one.

[29]  O. Gascuel,et al.  New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. , 2010, Systematic biology.

[30]  M. Rossmann,et al.  Structural and Virological Studies of the Stages of Virus Replication That Are Affected by Antirhinovirus Compounds , 2004, Journal of Virology.

[31]  F. Hayden,et al.  Rhinovirus Infections in Hematopoietic Stem Cell Transplant Recipients with Pneumonia , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  R. Manfredi,et al.  Bacteremia and respiratory involvement byAlcaligenes xylosoxidans in patients infected with the human immunodeficiency virus , 1997, European Journal of Clinical Microbiology and Infectious Diseases.

[33]  M. Rossmann,et al.  The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle. , 1997, Structure.

[34]  J. Vadolas,et al.  Neutralization epitopes of human rhinovirus type 2. , 1990, The Journal of general virology.

[35]  B. Sherry,et al.  Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14 , 1986, Journal of virology.